5-Azacytidine (NSC 102816) in refractory germ cell tumors. A phase II trial of the Eastern Cooperative Oncology Group.
Roth
B J
BJ
Indiana University Medical Center, Indianapolis.
Elson
P
P
Sledge
G W
GW
Einhorn
L H
LH
Trump
D L
DL
D001374:Azacitidine / Q000627:therapeutic use* / Q000633:toxicity; D018237:Germinoma / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008479:Mediastinal Neoplasms / Q000188:drug therapy; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy; D013736:Testicular Neoplasms / Q000188:drug therapy
D001374:Azacitidine